<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Mooghali M</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To evaluate the prevalence and accuracy of industry-related financial conflict of interest (COI) disclosures among US physician guideline authors.&lt;h4>Design&lt;/h4>Cross-sectional study.&lt;h4>Setting&lt;/h4>Clinical practice guidelines published by the Council of Medical Specialty Societies in 2020.&lt;h4>Participants&lt;/h4>US physician guideline authors.&lt;h4>Main outcome measures&lt;/h4>Financial COI disclosures, both self-reported and determined using Open Payments data.&lt;h4>Results&lt;/h4>Among 270 US physician authors of 20 clinical practice guidelines, 101 (37.4%) disclosed industry-related financial COIs, whereas 199 (73.7%) were found to have received payments from industry when accounting for payments disclosed through Open Payments. The median payments received by authors during the 3-year period was US$27 451 (IQR, US$1385-US$254 677). Comparing authors' self-disclosures with Open Payments, 72 (26.7%) of the authors accurately disclosed their financial COIs, including 68 (25.2%) accurately disclosing no financial COIs and 4 (1.5%) accurately disclosing a financial COI. In contrast, 101 (37.4%) disclosed no financial COIs and were found to have received payments from industry, 23 (8.5%) disclosed a financial COI but had under-reported payments received from industry, 14 (5.2%) disclosed a financial COI but had over-reported payments received from industry and 60 (22.2%) disclosed a financial COI but were found to have both under-reported and over-reported payments received from industry. We found that inaccurate COI disclosure was more frequent among professors compared with non-professors (81.9% vs 63.5%; p&lt;0.001) and among males compared with females (77.7% vs 64.8%; p=0.02). The accuracy of disclosures also varied among medical professional societies (p&lt;0.001).&lt;h4>Conclusions&lt;/h4>Financial relationships with industry are common among US physician authors of clinical practice guidelines and are often not accurately disclosed. To ensure high-quality guidelines and unbiased recommendations, more effort is needed to minimise existing COIs and improve disclosure accuracy among panel members.</pubmed_abstract><journal>BMJ open</journal><pagination>e069115</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9872463</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study.</pubmed_title><pmcid>PMC9872463</pmcid><pubmed_authors>Mooghali M</pubmed_authors><pubmed_authors>Glick L</pubmed_authors><pubmed_authors>Ramachandran R</pubmed_authors><pubmed_authors>Ross JS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study.</name><description>&lt;h4>Objective&lt;/h4>To evaluate the prevalence and accuracy of industry-related financial conflict of interest (COI) disclosures among US physician guideline authors.&lt;h4>Design&lt;/h4>Cross-sectional study.&lt;h4>Setting&lt;/h4>Clinical practice guidelines published by the Council of Medical Specialty Societies in 2020.&lt;h4>Participants&lt;/h4>US physician guideline authors.&lt;h4>Main outcome measures&lt;/h4>Financial COI disclosures, both self-reported and determined using Open Payments data.&lt;h4>Results&lt;/h4>Among 270 US physician authors of 20 clinical practice guidelines, 101 (37.4%) disclosed industry-related financial COIs, whereas 199 (73.7%) were found to have received payments from industry when accounting for payments disclosed through Open Payments. The median payments received by authors during the 3-year period was US$27 451 (IQR, US$1385-US$254 677). Comparing authors' self-disclosures with Open Payments, 72 (26.7%) of the authors accurately disclosed their financial COIs, including 68 (25.2%) accurately disclosing no financial COIs and 4 (1.5%) accurately disclosing a financial COI. In contrast, 101 (37.4%) disclosed no financial COIs and were found to have received payments from industry, 23 (8.5%) disclosed a financial COI but had under-reported payments received from industry, 14 (5.2%) disclosed a financial COI but had over-reported payments received from industry and 60 (22.2%) disclosed a financial COI but were found to have both under-reported and over-reported payments received from industry. We found that inaccurate COI disclosure was more frequent among professors compared with non-professors (81.9% vs 63.5%; p&lt;0.001) and among males compared with females (77.7% vs 64.8%; p=0.02). The accuracy of disclosures also varied among medical professional societies (p&lt;0.001).&lt;h4>Conclusions&lt;/h4>Financial relationships with industry are common among US physician authors of clinical practice guidelines and are often not accurately disclosed. To ensure high-quality guidelines and unbiased recommendations, more effort is needed to minimise existing COIs and improve disclosure accuracy among panel members.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-04T12:21:00.558Z</modification><creation>2025-04-04T12:21:00.558Z</creation></dates><accession>S-EPMC9872463</accession><cross_references><pubmed>36690402</pubmed><doi>10.1136/bmjopen-2022-069115</doi></cross_references></HashMap>